Abbott gets FDA nod, faces uphill climb taking on Edwards, Medtronic in TAVR market

Abbott gets FDA nod, faces uphill climb taking on Edwards, Medtronic in TAVR market

Source: 
Medtech Dive
snippet: 

FDA has approved Abbott's Portico transcatheter aortic valve replacement system, setting the company up to challenge Edwards Lifesciences and Medtronic for a major market.